abrdn Life Sciences Investors
HQL
72 hedge funds and large institutions have $125M invested in abrdn Life Sciences Investors in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 13 closing their positions.
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
1.45% less ownership
Funds ownership: 36.15% → 34.7% (-1.4%)
3% less funds holding
Funds holding: 74 → 72 (-2)
15% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 20
16% less capital invested
Capital invested by funds: $149M → $125M (-$24.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$1.87M |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$1.75M |
| 3 |
PCM
Penserra Capital Management
Orinda,
California
|
+$744K |
| 4 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$574K |
| 5 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
+$557K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$2.59M |
| 2 |
AIA
Absolute Investment Advisers
Rosemary Beach,
Florida
|
-$2.05M |
| 3 |
Morgan Stanley
New York
|
-$1.79M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$1.65M |
| 5 |
1CP
1607 Capital Partners
Richmond,
Virginia
|
-$1.48M |
HQL Hedge Fund Activity: Q4 2024 in Review
72 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q4 2024, worth a combined $125M — down 16% from $149M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new HQL positions and 13 closed out — a net gain of 1 holder — while 17 added to existing stakes and 20 trimmed.
The largest buyer was LPL Financial, adding an estimated $1.87M. The largest seller was Cetera Investment Advisers, exiting entirely with an estimated $2.59M sold.
- 72 institutional investors held abrdn Life Sciences Investors (HQL) as of Q4 2024, down from 74 in Q3 2024.
- Funds reported $125M of abrdn Life Sciences Investors stock for Q4 2024, down 16% quarter-over-quarter.
- 14 funds opened new abrdn Life Sciences Investors positions in Q4 2024 and 13 closed out, a net change of +1 holder.
- The largest abrdn Life Sciences Investors buyer in Q4 2024 was LPL Financial, an estimated $1.87M added.
- The largest abrdn Life Sciences Investors seller in Q4 2024 was Cetera Investment Advisers, an estimated $2.59M sold.
Based on aggregated 13F filings for Q4 2024.